Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
The last chapter deals with the normalipidemic (latent) dyslipoproteinemias, their pathobiochemistry, clinical aspects and the risk of atherosclerosis. In conclusion, the authors sum up the more recent views on the dysbalance of prostaglandins in relation to the cardiovascular diseases, the functions of the vascular wall and blood paletets in atherogenesis.
Choluj
B
B
Department of Clinical Biochemistry, Central Military Hospital, Prague, Czechoslovakia.
D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology*; D006801:Humans; D008049:Lipase / Q000097:blood; D008052:Lipid Metabolism, Inborn Errors / Q000097:blood / Q000150:complications*; D008055:Lipids / Q000097:blood; D008071:Lipoprotein Lipase / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D008049:Lipase; D008071:Lipoprotein Lipase